Motor Neuron Disease (MND) is a neurodegenerative disease that can be difficult to confidently diagnose during its early stages due to misinterpretation of signs and symptoms as other neurodegenerative diseases. This is an important issue, as confident diagnosis early in disease would ultimately allow earlier treatment to delay or halt the disease along with aiding in possible treatment monitoring. This may be achieved through the discovery of biomarkers to enable clinicians, patients and families with a clearer understanding of the disease and improve patient outcomes. Biomarkers can be elevated/reduced protein levels found within bodily fluids such as blood plasma. These biomarkers are easily detectable and indicate to a clinician whether a disease is present in a patient. From studying biomarkers, a diagnosis can be obtained, and the measurement of disease progression can be monitored. Additionally, medications could be personalised to the patients to ensure best possible outcomes for both the patient in management of disease and quality of life. This project will use protein discovery and analysis techniques to identify and target potential biomarkers from MND patient plasma samples. The identification of biomarkers in this research aims to: 1. Increase the understanding of disease diagnosis and progression and in turn the disease pathology of MND. 2. Create methods for researching biomarkers for diagnosis and prognosis that can be applied to future studies when using protein (proteomic) and molecular techniques.
|Short title||Proteomic Identification of Biomarkers in MND Patient Plasma|
|Effective start/end date||18/05/19 → 18/05/22|